Tesamorelin

a.k.a. Egrifta · TH9507

FDA-approved GHRH for visceral fat research

💉 Subcutaneous Injection

Purity

≥98%

Form

Lyophilized Powder

Storage

-20°C

Research Applications

Fat LossAnti-Aging

Select Size

Quantity

Total

$40.00

Research Use Only · Not for human consumption. Intended for in vitro laboratory and research applications.

Tesamorelin is an FDA-approved GHRH analog specifically studied for reducing visceral fat. It has the best research specifically for belly fat.

Tesamorelin stimulates GH release which then promotes lipolysis, particularly in visceral adipose tissue. It has unique efficacy for abdominal fat.

Related Peptides

Long-acting GHRH - once or twice weekly dosing

HGH fragment for fat metabolism without growth effects

Bioidentical GHRH - the most natural GH stimulation

$40.00

2mg (Single Vial) × 1